Building upon her previous research on the role of transcription factor SIX1 in sarcoma progression, Heide Ford, PhD, associate director of basic research at the University of Colorado Cancer Center, recently published a paper, in collaboration with CU Cancer Center members Paul Jedlicka, MD, and Jim Costello, PhD, in the journal Nature Communications showing that SIX1 plays a very different role in Ewing sarcoma than it does in other sarcomas — the general term for a broad group of cancers that can form in various locations in the body, including the bones and the soft tissue that connects, supports, and surrounds other body structures.
CU Anschutz
Anschutz Cancer Pavilion
1665 North Aurora Court
2004
Aurora, CO 80045